Triple-negative breast cancer (TNBC) comprises 10–15% of all breast cancers. It is a very heterogeneous disease, ...

A common anti-nausea drug has been linked to improved survival rates in women with early-stage breast cancer, particularly those with more aggressive triple-negative breast cancer, a study said on ...

A group of campaigners, including some from Surrey and Sussex, have met Health Secretary Wes Streeting in a call for more ...

A new study has found that a commonly prescribed anti-nausea medication is associated with a better prognosis for women with ...

Fact checked by Nick Blackmer Karen Peterson was diagnosed with stage 1 triple-negative breast cancer in 2015. After undergoing three months of chemotherapy with difficult side effects, she made the ...

With ever-growing treatment options, clinical care access and a new focus on integrative strategies, cancer centers are constantly upgrading their services and options for patients. Becker’s asked ...

The Trump administration's broadsides against scientific research have caused unprecedented upheaval at the National Cancer ...

With the rise in early onset cancer rates and mortality for breast, pancreatic, and gastric cancers, a wide and growing body ...

A University of Arizona cancer research lab, facing difficulties in getting federal funding, has started a crowdfunding ...

How common is breast cancer? Breast cancer is the most common cancer in women in the United States, except for skin cancers. It accounts for about 30% (or 1 in 3) of all new female cancers each year.

The sessions combine an artistic outlet with a place where breast cancer survivors and patients can share their experiences.

A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...